Analysis of Control Arm Quality in Randomized Clinical Trials Leading to Anticancer Drug Approval by the US FDA
This quality improvement study analyzed the quality of control arms in pivotal randomized clinical trials of anticancer drugs that led to approval by the US Food and Drug Administration between January 1, 2013, and July 31, 2018.